Nature's Sunshine Reports Third Quarter 2026 Results
NATURES SUNSHINE PRODUCTS INC (NATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Nature's Sunshine Reports Third Quarter 2026 Results LEHI, Utah – November 4, 2026 – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results f
How this was made
The 30-second read
Why it matters
The earnings miss and updated guidance are the primary new facts, making this the first report of the Q3 results.
Market read
First‑time disclosure of Q3 2026 performance and revised outlook, likely prompting short‑term price adjustment.
What to watch
Strong cash position ($89.4 M) and zero debt provide flexibility for strategic investments.
Background
The filing is an SEC Form 8‑K Item 2.02 earnings release for Nature's Sunshine Products, Inc.
Ticker impact
Nature's Sunshine reported Q3 2026 results with a 9% drop in net sales and updated full‑year sales guidance to $460‑$470 million.
downward pressure as investors price in weaker sales and updated outlook
Revenue decline, margin compression and a cut to full‑year sales range signal weaker demand, prompting sell‑side sentiment.
Market effects
Herbal and nutritional supplement sector may see broader scrutiny as sales pressure emerges in China.
North American and Asian markets could see modest downside in health‑product stocks.
Limited; impact confined to niche consumer‑health segment.
Counterpoint
If the company successfully restructures its China operations, the sales dip may be temporary, offering a buying opportunity.
Key entities
- companyNature's Sunshine Products, Inc.
US‑listed herbal supplement maker (Nasdaq: NATR).
